Welcome to the IMPALA Consortium’s podcast series, where we discuss and share insights from various IMPALA members on topics relevant to advanced analytics and digital technologies in biopharmaceutical Quality.
In this episode, we share an important update on IMPALA’s mission, scope, and vision, and how the organization is expanding its focus to meet the demands of a rapidly changing biopharma landscape. While IMPALA was originally centered on advanced analytics, we are now broadening our impact to include a significant digital transformation agenda—advancing both data and digital capabilities across GCP and GVP. Hosted by Jeremy Jones, this episode features a dynamic discussion with Roshan Dsouza, Mike Pelosi, and Megan Selby, exploring the mindset shift underway within IMPALA and what it means for the projects and partnerships driving the future of quality across biotech and biopharma. If you're interested in how our industry is moving beyond traditional models toward digitally enabled, AI-powered, and risk-based quality, this conversation is for you.
In this episode, led by Kiernen Trivett (Roche) we feature around table discussion developed by one of our IMPALA Work Product Teams last year as part of staff development and knowledge sharing on modern R&D Quality practices. We explore how quality can enable key business outcomes by leveraging new technology and data to maximize quality oversight—while providing robust, risk-based assurance to regulatory agencies to support effective decision-making. The discussion highlights the work of the Critical to Quality Assessment Report Work Product Team (CAR WPT), which is driving a fundamental shift in the quality paradigm—moving away from retrospective, time-consuming traditional QA activities toward approaches that accelerate approvals and patient access to innovative therapies.
In this episode, Jeremy is joined by new members of the IMPALA Consortium: Meera Nagaria, Senior Data Scientist at J&J; Lucie Régné Martos, Clinical Quality Performance & Risk Management Head at Sanofi; Cedric Liu, Associate Director, AI/ML at Biogen; CJ Jassal, Head of Quality and Governance at Biogen; and Deepak Bandyopadhyay, Data Science Group Leader at J&J. Tune in and listen as they discuss the shift towards data-driven clinical audit site selection, the challenges in implementing these strategies, innovations in current practices, and how the IMPALA Consortium is advancing data-driven methodologies in clinical trial site selection.
In this episode, Sharon and Jeremy are joined by Ryan Dugan, Associate Director, Analytics & Insights, MRL QA at Merck. Join us as we explore the world of Artificial Intelligence (AI) and its fascinating subset, Generative AI. We also discuss the sudden surge of interest and advancements in Generative AI over the past year, attributing it to its promising applications in healthcare and touch upon the ethical considerations that come with using this technology. We then shift our focus to the impact of Generative AI on the Pharma QA space where Ryan shares some examples of its applications at Merck. Tune in to gain a deeper understanding of Generative AI and its implications in the Healthcare Industry!
In this episode, Sharon and Jeremy are joined by Pekka Tiikkainen, Lead of IMPALA’s Work Product Package on Anomaly Detection in Clinical Data, as well as Data Scientists Björn Koneswarakantha and Frederik Collin. Together, they discuss their individual journeys into the field of Data Science and provide insights into how this area has evolved over time. Furthermore, we will delve into the future of Data Science, exploring the possibilities and potential it holds.
In this episode Sharon and Jeremy are joined by Mike Pelosi, Co-Chair of IMPALA’s Strategic Steering Committee and Roshan D’Souza, Chair of IMPALA and Member of the Education Work Product Team. Listen as they take it back to the basics and answer fundamental questions such as: What exactly do we mean by Data? How are we using Data we are generating? Has data replaced Oil as the most valuable resource in the world?
In this episode Sharon and Jeremy are joined by Mike Pelosi, Co-Chair of IMPALA’s Strategic Steering Committee and Co-Lead of the Education Work Product Team, Joanna North, Co-Lead of the Education Work Product Team and Roshan D’Souza, Member of the Education Work Product Team. Listen as they delve into the industry-leading initiatives of the IMPALA Education Work Product Team and learn about what’s key to becoming a Data-Driven Quality Professional in the dynamic world of biopharma.
In this episode Sharon and Jeremy are joined by Timothe Menard, Co-Founder of IMPALA and Mike Pelosi, Co-Chair of IMPALA’s Strategic Steering Committee and Co-Lead of the Education Work Product Team. Listen as we discuss what IMPALA is and what they are trying to achieve. You’ll also get the chance to hear more about the current IMPALA work products, Tim and Mike’s vision for the future of IMPALA before they wrap up with how you can get involved!